EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice

BACKGROUND: The prognosis of metastatic non-small cell lung cancer (NSCLC) is still poor. Activating epithelial growth factor receptor (EGFR) mutations are important genetic alterations with dramatic therapeutical implications. Up to now, in contrast to Asian populations only limited data on the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Gahr, S, Stoehr, R, Geissinger, E, Ficker, J H, Brueckl, W M, Gschwendtner, A, Gattenloehner, S, Fuchs, F S, Schulz, C, Rieker, R J, Hartmann, A, Ruemmele, P, Dietmaier, W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790166/
https://www.ncbi.nlm.nih.gov/pubmed/24002608
http://dx.doi.org/10.1038/bjc.2013.511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790166/
https://www.ncbi.nlm.nih.gov/pubmed/24002608
http://dx.doi.org/10.1038/bjc.2013.511

Ejemplares similares